NVN2 (Stavzor 500 mg)
Generic Name: valproic acid
Pill with imprint NVN2 is Orange, Elliptical / Oval and has been identified as Stavzor 500 mg. It is supplied by Noven Pharmaceuticals.
Stavzor is used in the treatment of epilepsy; seizure prevention; schizoaffective disorder; mania; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Stavzor 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVN2
Stavzor
- Generic Name
- valproic acid
- Imprint
- NVN2
- Strength
- 500 mg
- Color
- Orange
- Size
- 15.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Noven Pharmaceuticals
- National Drug Code (NDC)
- 68968-3500
- Inactive Ingredients
-
ammonia, gelatin, glycerin, methacrylic acid - methyl methacrylate copolymer (1:1), triethyl citrate, water, FD&C Yellow No. 6
Note: Inactive ingredients may vary.
More about Stavzor (valproic acid)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- 1 Review
- Drug class: fatty acid derivative anticonvulsants
- FDA Alerts (5)
- FDA Approval History
Consumer resources
Other brands: Valproate Sodium, Depakene, Depacon
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
